238P NMD670, a First-in-class Skeletal Muscle ClC-1 Inhibitor in Myasthenia Gravis: the SYNAPSE-MG Dose-Finding StudyT. Gidaro, T.S. Grønnebæk, C. Cornwall, J. Gupte, C. Sampson, V. Kiyasova, T.H. Pedersen, J.A. QuirozNeuromuscular Disorders（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
